Birkenstock starts trading today in key test of IPO market Birkenstock starts trading today in key test of IPO market Birkenstock starts trading today in key test of IPO market

Birkenstock starts trading today in key test of IPO market

Equities 5 minutes to read
Peter Garnry

Head of Equity Strategy

Summary:  Birkenstock starts trading today on NYSE under the Saxo ticker symbol BIRK:xnys with its shares priced yesterday at the midpoint of the pricing range valuing the company at UDS 8.6bn. Birkenstock is expected to deliver revenue growth of 21% in FY23 (ending 30 September 2023) and a strong adjusted EBITDA margin above 35% reflecting the strong brand and premium pricing. Some key risks to consider are the equity valuation, concentrated revenue profile with 75% of revenue coming from just five core products, and then a bit low return on invested capital.

Key points in this equity note:

  • Birkenstock IPO was priced yesterday at the midpoint of the price range valuing the company at $8.6bn. The stock starts trading today with the Saxo ticker symbol BIRK:xnys

  • Birkenstock has a strong brand and has showed resilient growth during the pandemic with revenue growth expected at 21% in FY23 (ending 30 September 2023)

  • Some key risks about the Birkenstock business are a higher than average equity valuation, high revenue concentration in just five core products, and a bit low return on invested capital

A strong brand with attractive growth profile and profitability

Birkenstock is an iconic German-based sandal and shoe company and the next company to IPO this year following recent IPOs from Arm and Instacart. The stock was priced yesterday at $46 per share which was around the midpoint of the pricing range valuing the company at $8.6bn and raising $1.5bn. Birkenstock starts trading today on NYSE under the Saxo ticker symbol BIRK:xnys.

Investor appetite for Birkenstock has been solid and the LVMH Chairman Bernard Arnault’s family holding company has already invested in Birkenstock and has indicated that it is willing to increase its investment in Birkenstock. This is seen by many investors as a good sign for the outlook of the Birkenstock brand as LVMH is the leading luxury conglomerate in the world. The strength of the Birkenstock brand is also evident in the prospectus material. Birkenstock has strong US brand awareness and a high willingness to repurchase with each US customer owning more than three pairs of Birkenstock sandals or shoes.

Source: Birkenstock prospectus

The company has also successfully expanded its direct-to-consumer business to 38% which has been a key driver of the recent EBITDA margin expansion from 27% in FY20 (ending 30 September 2020) to expected 35.5% in FY23 (ending 30 September 2023). Revenue in FY23 is expected to be around $1.5bn up 21% y/y but revenue growth is likely to decrease further as global consumer spending is normalising post the pandemic.

In addition, the future growth of the company lies outside North America and Europe which today are 90% of revenue. Another underlying positive factor for the outlook is that revenue is almost equally balanced across all age groups suggesting that Birkenstock’s brand appeals to young people and thus future can be relied on. In addition, the customer base is predominantly high income groups and thus the company is able to sell its sandals and shoes at premium prices improving the profitability of the business.

There are also a few negative things to highlight about the business. With around $4bn in deployed capital in the business the return on invested capital could be better at just around 8% for the FY23. However, as the company becomes a publicly listed company this is likely to be a key priority going forward. Birkenstock also has a high product concentration with 75% of revenue coming just five core products. In terms of equity valuation it is set such that Birkenstock is valued at a premium to say Adidas. Birkenstock is valued at a FY24 EV/EBITDA multiple of around 18x compared to Adidas at around 15.3x, but Birkenstock also has a higher growth profile due to low revenue in Asia and more potential for direct-to-consumer penetration.

Post IPO performance of Arm, Klaviyo, and Instacart

Birkenstock is the fourth important IPO this year as the IPO market is coming back as investors are now more willing to invest in IPOs given the outlook this year has changed from certainty of recession to growth being robust. Of the three recent IPOs from Arm, Klaviyo and Instacart two of them have seen gains since the IPO. It is only Instacart that is down since the IPO.

Source: Bloomberg

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (
- Analysis Disclaimer (
- Notification on Non-Independent Investment Research (

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.